Related Articles
ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS
GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER
AUGMENTATION OF PROTECTIVE IMMUNOTHERAPY AGAINST METASTATIC ESB LYMPHOMA-CELLS BY COMBINING IMMUNE CELL TRANSFER WITH HOST IRRADIATION, ANTIGEN RESTIMULATION AND/OR ANTI-TNF-ALPHA ANTIBODY TREATMENT
In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination.
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo